Alnylam Pharmaceuticals
ALNY
#378
Rank
โ‚ฌ51.98 B
Marketcap
393,48ย โ‚ฌ
Share price
-1.55%
Change (1 day)
62.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company